6.
Sikorsky J, Primerano D, Fenger T, Denvir J
. DNA damage reduces Taq DNA polymerase fidelity and PCR amplification efficiency. Biochem Biophys Res Commun. 2007; 355(2):431-7.
PMC: 1945218.
DOI: 10.1016/j.bbrc.2007.01.169.
View
7.
Liu Y, Li H, Zhu J, Zhang Y, Liu X, Li R
. The Prevalence and Concurrent Pathogenic Mutations of in Northeast Chinese Non-small-cell Lung Cancer Patients. Cancer Manag Res. 2021; 13:2447-2454.
PMC: 7979353.
DOI: 10.2147/CMAR.S282617.
View
8.
Zhang X, He N, Gu D, Wickliffe J, Salazar J, Boldogh I
. Genetic Evidence for XPC-KRAS Interactions During Lung Cancer Development. J Genet Genomics. 2015; 42(10):589-596.
PMC: 4643398.
DOI: 10.1016/j.jgg.2015.09.006.
View
9.
Paris C, Do P, Mastroianni B, Dixmier A, Dumont P, Pichon E
. Association between lung cancer somatic mutations and occupational exposure in never-smokers. Eur Respir J. 2017; 50(4).
DOI: 10.1183/13993003.00716-2017.
View
10.
Hansen A, Mathiesen L, Pedersen M, Knudsen L
. Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies--a review. Int J Hyg Environ Health. 2008; 211(5-6):471-503.
DOI: 10.1016/j.ijheh.2007.09.012.
View
11.
Yamano Y, Hara K, Ichiba M, Hanaoka T, Pan G, Nakadate T
. Urinary 1-hydroxypyrene as a comprehensive carcinogenic biomarker of exposure to polycyclic aromatic hydrocarbons: a cross-sectional study of coke oven workers in China. Int Arch Occup Environ Health. 2013; 87(7):705-13.
DOI: 10.1007/s00420-013-0913-6.
View
12.
Ferrer I, Zugazagoitia J, Herbertz S, John W, Paz-Ares L, Schmid-Bindert G
. KRAS-Mutant non-small cell lung cancer: From biology to therapy. Lung Cancer. 2018; 124:53-64.
DOI: 10.1016/j.lungcan.2018.07.013.
View
13.
Gou L, Niu F, Wu Y, Zhong W
. Differences in driver genes between smoking-related and non-smoking-related lung cancer in the Chinese population. Cancer. 2015; 121 Suppl 17:3069-79.
DOI: 10.1002/cncr.29531.
View
14.
de Oliveira Alves N, Pereira G, Di Domenico M, Costanzo G, Benevenuto S, de Oliveira Fonoff A
. Inflammation response, oxidative stress and DNA damage caused by urban air pollution exposure increase in the lack of DNA repair XPC protein. Environ Int. 2020; 145:106150.
DOI: 10.1016/j.envint.2020.106150.
View
15.
Uras I, Moll H, Casanova E
. Targeting Mutant Non-Small-Cell Lung Cancer: Past, Present and Future. Int J Mol Sci. 2020; 21(12).
PMC: 7352653.
DOI: 10.3390/ijms21124325.
View
16.
Maitre A, Petit P, Marques M, Herve C, Montlevier S, Persoons R
. Exporisq-HAP database: 20 years of monitoring French occupational exposure to polycyclic aromatic hydrocarbon mixtures and identification of exposure determinants. Int J Hyg Environ Health. 2018; 221(2):334-346.
DOI: 10.1016/j.ijheh.2017.12.008.
View
17.
Riely G, Marks J, Pao W
. KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc. 2009; 6(2):201-5.
DOI: 10.1513/pats.200809-107LC.
View
18.
Han F, Guo H, Hu J, Zhang J, Ying Q, Zhang H
. Sources and health risks of ambient polycyclic aromatic hydrocarbons in China. Sci Total Environ. 2019; 698:134229.
DOI: 10.1016/j.scitotenv.2019.134229.
View
19.
Hainaut P, Pfeifer G
. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis. 2001; 22(3):367-74.
DOI: 10.1093/carcin/22.3.367.
View
20.
Quezada-Maldonado E, Sanchez-Perez Y, Chirino Y, Garcia-Cuellar C
. Airborne particulate matter induces oxidative damage, DNA adduct formation and alterations in DNA repair pathways. Environ Pollut. 2021; 287:117313.
DOI: 10.1016/j.envpol.2021.117313.
View